Equifax Total Cost of Revenue increased by 16.0% to $767.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.8%, from $656.70M to $767.10M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 7.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $483.00M | $489.00M | $525.60M | $553.40M | $542.10M | $542.50M | $539.20M | $580.40M | $588.00M | $585.20M | $581.60M | $627.70M | $630.90M | $645.20M | $615.00M | $656.70M | $664.60M | $663.20M | $661.20M | $767.10M |
| QoQ Change | — | +1.2% | +7.5% | +5.3% | -2.0% | +0.1% | -0.6% | +7.6% | +1.3% | -0.5% | -0.6% | +7.9% | +0.5% | +2.3% | -4.7% | +6.8% | +1.2% | -0.2% | -0.3% | +16.0% |
| YoY Change | — | — | — | — | +12.2% | +10.9% | +2.6% | +4.9% | +8.5% | +7.9% | +7.9% | +8.1% | +7.3% | +10.3% | +5.7% | +4.6% | +5.3% | +2.8% | +7.5% | +16.8% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Workforce Solutions | $233.00M | $232.80M | $237.90M | $236.90M | $249.00M |
| International | $157.50M | $166.40M | $157.40M | $160.70M | $163.90M |
| U.S. Information Solutions | — | — | — | $232.50M | — |
| Total | $656.70M | $664.60M | $663.20M | $661.20M | $767.10M |